blinatumomab:

Wen Gao1,2, Jingwei Yu1, Yifei Sun1

  • 1State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine/Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Sino-US Center for Lymphoma and Leukemia Research, Tianjin, 300060, China.

BMC medicine
|February 6, 2025
PubMed
概括

布利纳莫马布可以引起神经系统毒性 (NST),在男性和年轻人中更常见. 年龄可以防止致命的NST,而细胞因子释放综合征增加了死亡风险.